{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:24:53Z","timestamp":1767900293098,"version":"3.49.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,5,15]]},"DOI":"10.2169\/internalmedicine.5934-20","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T22:08:55Z","timestamp":1607983735000},"page":"1607-1610","source":"Crossref","is-referenced-by-count":9,"title":["Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 Antibodies"],"prefix":"10.2169","volume":"60","author":[{"given":"Shinichi","family":"Wada","sequence":"first","affiliation":[{"name":"Department of Neurology, Kansai Electric Power Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kansai Electric Power Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kansai Electric Power Hospital, Japan"},{"name":"Division of Clinical Neurology, Kansai Electric Power Medical Research Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Tsuzaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kansai Electric Power Hospital, Japan"},{"name":"Division of Clinical Neurology, Kansai Electric Power Medical Research Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kansai Electric Power Hospital, Japan"},{"name":"Division of Clinical Neurology, Kansai Electric Power Medical Research Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kesner VG, Oh SJ, Dimachkie MM, Barohn RJ. Lambert-Eaton myasthenic syndrome. Neuro Clin 36: 379-394, 2018.","DOI":"10.1016\/j.ncl.2018.01.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sutton I, Winer JB. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci 102: 475-486, 2002.","DOI":"10.1042\/cs1020475"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stich O, Klages E, Bischler P, et al. SOX antibodies in sera from patients with paraneoplastic neurological syndromes. Acta Neurol Scand 125: 326-331, 2012.","DOI":"10.1111\/j.1600-0404.2011.01572.x"},{"key":"4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/01.WNL.0000037485.56217.5F","volume":"59","author":"YK Nakao","year":"2002","unstructured":"4. Nakao YK, Motomura M, Fukudome T, et al. Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology 59: 1773-1775, 2002.","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Titulaer MJ, Wirtz PW, Kuks JBM, et al. The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients. J Neuroimmunol 201-202: 153-158, 2008.","DOI":"10.1016\/j.jneuroim.2008.05.025"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Koriyama H, Kyoraku I, Yamashita S, Shiomi K, Matsumoto N, Nakazato M. Synchronous appearance and improvement with anticancer chemotherapy of paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome complicated with small cell lung cancer. Rinsho Shinkeigaku 53: 104-108, 2013 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.53.104"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lipka AF, Verschuuren JJGM, Titulaer MJ. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma. Ann N Y Acad Sci 1275: 70-77, 2012.","DOI":"10.1111\/j.1749-6632.2012.06772.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tschernatsch M, Gross O, Kneifel N, Kaps M, Blaes F. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes. Autoimmun Rev 8: 549-551, 2009.","DOI":"10.1016\/j.autrev.2009.01.015"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Sabater L, Titulaer M, Saiz A, Verschuuren A, Gure AO, Graus F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 70: 924-928, 2008.","DOI":"10.1212\/01.wnl.0000281663.81079.24"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sabater L, Hoftberger R, Boronat A, Saiz A, Dalmau J, Graus F. Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS One 8: e60438, 2013.","DOI":"10.1371\/journal.pone.0060438"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Titulaer MJ, Klooster R, Potman M, et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. J Clin Incol 27: 4260-4267, 2009.","DOI":"10.1200\/JCO.2008.20.6169"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Berger B, Dersch R, Ruthardt E, Rasiah C, Rauer S, Stich O. Prevalence of anti-SOX-1 reactivity in various neurological disorders. J Neurol Sci 369: 342-346, 2016.","DOI":"10.1016\/j.jns.2016.09.002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Toyoda Y, Nakayama T, Kusunoki Y, Iso H, Suzuki T. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer 98: 1602-1607, 2008.","DOI":"10.1038\/sj.bjc.6604351"},{"key":"14","unstructured":"14. Miki S, Nomura Y, Hayashi N, et al. Prospective study of spatial distribution of missed lung nodules by readers in CT lung screening using computer-assisted detection. Acad Radiol. Forthcoming."},{"key":"15","unstructured":"15. Kanamori K, Yahata T, Otsuka K, Imanaka M, Yokota I. A case of small cell lung carcinoma without apparent primary lesion accompanying Lambert-Eaton myasthenic syndrome. Nihon Kokyuki Gakkai Zasshi 47: 1151-1155, 2009 (in Japanese, Abstract in English)."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_5934-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T04:03:05Z","timestamp":1621051385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/10\/60_5934-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5934-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,15]]}}}